改善性结肠炎患者疾病相关和机械生物标志物的多矿物干预:随机试验结果
Muhammad N Aslam1, Danielle Kim Turgeon2, Henry D Appelman1
1Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.
PloS one
|December 8, 2025
概括
一种多矿产产品,Aquamin,在试点研究中改善了性结肠炎 (UC) 生物标志物和骨健康. 这表明,Aquamin可能是对轻度UC或UC缓解的有益,低成本疗法.
科学领域:
- 胃肠病学 胃肠病学
- 营养科学 营养科学
- 生物化学 生物化学
背景情况:
- 性结肠炎 (UC) 的管理仍然是一个挑战,需要新的治疗方法.
- 一种多矿产产品,Aquamin正在研究其在UC的潜在益处.
- 这项研究侧重于UC患者的试点生物标志物试验,这些患者患有轻度疾病或处于缓解状态.
研究的目的:
- 评估Aquamin在改善UC患者疾病相关生物标志物的疗效.
- 评估Aquamin对UC患者骨周转和骨矿物质密度的影响.
- 通过蛋白质组学分析,探索阿奎的作用背后的分子机制.
主要方法:
- 一个180天的随机,安慰剂对照试验,涉及28名UC患者.
- 在血清,便和活检中进行生物标志物分析 (CRP,fCAL,ALP,ALPI,骨循环标志物).
- 组织学评估 (盖博斯评分),DEXA扫描骨密度,以及基于质谱的蛋白质组学.
主要成果:
- 与安慰剂相比,180天的Aquamin治疗显著改善了所有测量的生物标志物.
- 在Aquamin组观察到部强度指数增加了7.3%,同时改善了骨矿物质密度和含量.
- 蛋白质组分析显示,Aquamin可以调高肠道屏障蛋白和抗炎分子,同时调低促炎标志物.
结论:
- 氨酸补充剂显示出改善UC患者疾病活性和骨健康的潜力.
- 这些发现表明,Aquamin是一种有前途的,无毒的,且具有成本效益的辅助疗法,用于轻度UC或UC缓解.
- 需要进一步的研究,以在更大的临床试验中证实这些初步发现.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
617
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
617
01:29Drugs for Treatment of Ulcerative Colitis in IBD
431
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
431
01:29Inflammatory Bowel Disease IV: Pharmacological Management
450
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
450
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
862
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
862
01:21Inflammatory Bowel Disease V: Surgical Management
428
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
428
01:26Peptic Ulcer Disease IV: Management
406
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
406